Abstract:Atherosclerosis is a chronic inflammatory disease of the arterial wall with hypercholesterolemia and inflammation representing two major pillars in its pathophysiology. A decade ago, studies unraveled how hypercholesterolemia influences inflammation and revealed that lipids orchestrate leukocyte homeostasis. Hypercholesterolemia-associated monocytosis and neutrophilia directly correlate with lesional leukocyte counts and lesion dimension in mice and with the incidence of cardiovascular events in humans.[1] [2] [3] In mice, for example, counts of circulating Ly6C hi inflammatory monocytes correlate with atherosclerotic lesion burden.[2] [4] Similarly, circulating neutrophil counts expand under hypercholesterolemia correlating with atherosclerotic plaque size and lesional neutrophil accumulation.[1] [5] [6] Analogous associations were already found in the 1970s, when it was noticed that peripheral leukocyte counts predict future cardiovascular events.[7] Very recently, these observations were extended by providing proof for the causality between high neutrophil counts and the risk for cardiovascular morbidity across several end points.[8] [9] Formyl-peptide receptor 1 (FPR1) is an ancient receptor for bacterial derived motifs including the needle cap protein of Yersinia pestis [10] as well as of formylated peptides that are released from all bacteria. Yet, given the fact that eukaryote mitochondria are of bacterial origin,[11] it is not surprising that mitochondrial damage in the case of cell necrosis releases host-derived formyl-peptides. Among circulating immune cells, FPR1 is predominantly expressed on neutrophils and hence lack of this receptor impairs neutrophil recruitment in the context of bacterial infections and tissue necrosis.[12] [13] [14] However, the role of FPR1 in vascular inflammation remains thus far unknown. Hence, we crossed FPR1-deficient ( Fpr1 −/− ) and apolipoprotein E-deficient ( Apoe −/− ) animals and fed these mice western diet (WD) or normal chow diet for 4 weeks and performed subsequent flow cytometric and histological sample assessment ([Fig. 1A]). Mice were sacrificed and body weight, plasma cholesterol, and triglyceride levels were determined but remained unaltered between the groups (data not shown). Subsequent analysis of leukocyte counts in blood, however, revealed hypercholesterolemia-associated neutrophilia only in Apoe −/− but not in Apoe −/− Fpr1 −/− animals ([Fig. 1B]). Interestingly, this effect could not be recapitulated in bone marrow or spleen of Apoe −/− Fpr1 −/− mice ([Fig. 1C, D]). The latter indicates a critical role for FPR1 in controlling neutrophil numbers in blood under hyperlipidemic conditions. Given that the frequency of annexin V + neutrophils in blood of FPR1 competent and deficient mice was not different, we concluded that neutrophil apoptosis was likely no contributor to lower neutrophil blood counts in FPR1-deficient mice ([Fig. 1E]). Importantly, the number of colony forming units (CFU) in bone marrow cells increased upon hyperlipidemia but remained unchanged between Apoe −/− and Apoe −/− FPR1 −/− mice ([Fig. 1F]). With apoptosis and production being unaltered, we assumed that possibly the mobilization of neutrophils from the bone marrow is impaired. To test this idea, we performed bromodeoxyuridine (BrdU) pulse labeling and quantified the appearance of BrdU-positive neutrophils in blood over time. In agreement with our hypothesis, neutrophils from FPR1-defcient mice exhibited impaired mobilization capacities ([Fig. 1G]). Preclinical and recent clinical data strongly suggest a correlation between circulating neutrophil counts and cardiovascular disease burden.[1] [8] Here, we analyzed a published human scRNAseq dataset of advanced atherosclerotic lesions (GSE155512,[15]) and an unpublished murine scRNAseq dataset of brachiocephalic arteries from Apoe −/− mice fed with WD for 16 weeks for cell-specific FPR1 expression. In both datasets, FPR1 expression was restricted to myeloid cells and in particular to neutrophils as evident from clustering of CSF1R and S100A8 together with FPR1 ([Fig. 1H] and data not shown). Further, we studied how lack of FPR1 impacts on early atherogenesis and lesion composition. Therefore, we analyzed the number of neutrophils and macrophages in aortic cell suspensions of WD fed Apoe −/− and Apoe −/− Fpr1 −/− mice. H -Abstract Truncated-

Antigen-Presenting Cell-Like Neutrophils Foster T Cell Response in Hyperlipidemic Patients and Atherosclerotic Mice

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

Interleukin-17-Producing CD4+ T Cells Promote Inflammatory Response and Foster Disease Progression in Hyperlipidemic Patients and Atherosclerotic Mice

A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice

Neutrophil's weapons in atherosclerosis

CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis

Adaptive Immune Response Signaling is Suppressed in Ly6Chigh Monocyte but Upregulated in Monocyte Subsets of ApoE-/- Mice — Functional Implication in Atherosclerosis

Neutrophil Heterogeneity Is Modified during Acute Lung Inflammation in Apoa1-/- Mice

Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice

OX40-OX40L interaction targets NFATc1 in ApoE-/- mice during atherogenesis

Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis

Resolving neutrophils through genetic deletion of TRAM attenuate atherosclerosis pathogenesis

Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming

In situ lipid-loading activates peripheral dendritic cell subsets characterized by cellular ROS accumulation but compromises their capacity to prime naïve T cells

Molecular and spatiotemporal characterization of cells in murine atherosclerotic plaques

Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE−/− mice

Oxhdl_3 and Oxldl Induce the Expression of IL-1β,IL-6,HLA-DR,and CD86 in THP-1 Monocyte-Derived Macrophages

Immune landscape and regulatory mechanisms in human atherosclerotic coronary plaques: Evidence from single-cell and bulk transcriptomics

Phosphorylcholine-Primed Dendritic Cells Aggravate the Development of Atherosclerosis in ApoE-/- Mice.

Giant phagocytes (Gφ) and neutrophil-macrophage hybrids in human carotid atherosclerotic plaques – An activated phenotype